News

January 12, 2015 Media

Japanese drugmakers addressing neglected tropical diseases, and not just out of altruism

The GHIT Fund and Japanese pharma partners Astellas and Esai were featured in the Jiji Press/Japan Times on January 6. Japans' pharmaceutical companies see their engagement in drug development for neglected diseases in the developing world as a sustainable "business for the future", not as philanthropy. GHIT's work has been a critical catalyst.

Japan Times: Japanese drugmakers addressing neglected tropical diseases, and not just out of altruism